OptiNose's (OPTN) CEO Peter Miller on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
OptiNose, Inc. (OPTN)
Last optinose, inc. earnings: 3/5 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.optinose.com
Company Research
Source: Seeking Alpha
OptiNose, Inc. (NASDAQ: OPTN ) Q1 2018 Earnings Conference Call May 14, 2018 8:00 AM ET Executives Peter Miller - CEO Keith Goldan - CFO Tom Gibbs - Chief Commercial Officer Jonathan Neely - VP, IR Analysts David Amsellem - Piper Jaffray Nicole Germino - BMO Capital Markets Randall Stanicky - RBC Capital Markets David Steinberg - Jefferies Operator Good day, ladies and gentlemen and welcome to the OptiNose Q1 2018 Earnings Conference Call. [Operator Instructions]. I would now like to turn the call over to Jonathan Neely, VP of Investor Relations. Please go ahead. Jonathan Neely Good morning and thank you for joining us today, as we review OptiNose's first quarter 2018 performance and our plans for 2018. I'm joined today by our CEO, Peter Miller; Ramy Mahmoud, our President and Chief Operating Officer; Keith Goldan, our CFO; and Tom Gibbs, our Chief Commercial Officer. The slides that will be presented on this call can be viewed on our web site,
Show less
Read more
Impact Snapshot
Event Time:
OPTN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPTN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPTN alerts
High impacting OptiNose, Inc. news events
Weekly update
A roundup of the hottest topics
OPTN
News
- OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.MarketBeat
- OptiNose, Inc. (NASDAQ: OPTN) had its price target raised by analysts at Lake Street Capital from $3.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- OptiNose granted FDA nod to expand labeling for sinusitis therapy [Seeking Alpha]Seeking Alpha
- XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps [Yahoo! Finance]Yahoo! Finance
- XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal PolypsGlobeNewswire
OPTN
Earnings
- 3/7/24 - Beat
OPTN
Sec Filings
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- OPTN's page on the SEC website